SFSIG
ACAD icon

San Francisco Sentry Investment Group’s Acadia Pharmaceuticals ACAD Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,325
Closed -$36K – 891
2018
Q2 		$36K Sell
2,325
-3,652
-61% -$65.1K 0.01% 417
2018
Q1 		$134K Buy
5,977
+250
+4% +$6.92K 0.04% 323
2017
Q4 		$172K Buy
5,727
+1,300
+29% +$41.6K 0.05% 281
2017
Q3 		$167K Sell
4,427
-52
-1% -$1.69K 0.06% 270
2017
Q2 		$125K Buy
+4,479
New +$133K 0.04% 279
2014
Q4 		– Sell
-2,790
Closed -$69K – 159
2014
Q3 		$69K Buy
2,790
+1,040
+59% +$24.3K 0.03% 264
2014
Q2 		$40K Buy
1,750
+1,450
+483% +$30.3K 0.02% 345
2014
Q1 		$7K Hold
300
– – ﹤0.01% 562
2013
Q4 		$7K Buy
+300
New +$7.08K ﹤0.01% 534

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return